Sustainability data can reveal risks and opportunities that traditional financial statements may miss. In this blog post, we ...

Research and insights professionals—skilled in crafting questions and working with a wide range of data sources—have an ...

AMT-130 has been granted the FDA’s Regenerative Medicine Advance Therapy (RMAT) designation and Breakthrough Therapy designation, the first therapy for Huntington’s disease to receive an RMAT ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...

Could your daily vitamins help to keep your body youthful? A new four-year study suggests that taking vitamin D daily might help slow down aging at the cellular level. Researchers found that people ...

We know from the phase 2 TROPHY-U-01 trial that sacituzumab govitecan is an active drug, with an objective response rate of ...

During the INMA World Congress of News Media, AI was by far the most-discussed topic. Here is a look at the use cases, ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of ...

A Concluding Statement describes the preliminary findings of IMF staff at the end of an official staff visit (or ‘mission’), in most cases to a member country. Missions are undertaken as part of ...

Event Details: SOL Strategies Second Quarter 2025 Financial Results Webcast and Conference Call Webcast Date: Monday, June 2, 2025, at 4:30 PM EST Live Call: (800) 245-3047 (U.S.) or (203) 518-9765 ...

BioNTech SE(Nasdaq: BNTX, "BioNTech" or "the Company") will present clinical trial data from select pipeline candidates across the Company's diversified oncology portfolio ...

Exposure to antibiotics following FMT may lead to recurrent CDI, suggesting the need for modified strategies to prevent recurrent CDI in some patients.